Sanofi, Regeneron's Libtayo hits hot streak with EU green light, NICE backing
admin 2nd July 2019 Uncategorised 0Sanofi and Regeneron’s Libtayo is two for two in the last two days—with European officials, that is. The immuno-oncology latecomer landed an EU green light and backing from England’s tough cost-effectiveness watchdogs in less than 48 hours.
More: Sanofi, Regeneron's Libtayo hits hot streak with EU green light, NICE backing
Source: fierce